Description
Corvalazid Oral Drops
Ingredients
Active ingredients: Ethyl ether of α-bromisovaleric acid, phenobarbital.
Mechanism of Action
Corvalazid combines the anxiolytic properties of ethyl ether of α-bromisovaleric acid with the sedative effects of phenobarbital, providing a synergistic action in managing anxiety disorders.
Pharmacological Properties
Corvalazid acts by modulating neurotransmitter levels in the brain, leading to a reduction in anxiety symptoms and promoting relaxation.
Indications for Use
Corvalazid oral drops are indicated for the relief of anxiety and tension.
Contraindications
Do not use Corvalazid oral drops if you are allergic to any of the ingredients or have a history of substance abuse.
Side Effects
Potential side effects of Corvalazid may include drowsiness, dizziness, and gastrointestinal disturbances. Consult your healthcare provider for more information.
Usage Instructions
Directions: Shake well before use. Take the prescribed amount orally, as directed by your healthcare provider.
Benefits Compared to Analogues
Corvalazid has shown superior efficacy in managing anxiety symptoms compared to some traditional anxiolytic medications, providing a comprehensive approach to anxiety relief.
Suitable Patient Groups
Corvalazid is suitable for adult patients experiencing anxiety disorders. Consult a healthcare provider for appropriate use in specific patient populations such as the elderly or individuals with comorbid conditions.
Storage and Shelf Life
Store Corvalazid oral drops in a cool, dry place away from direct sunlight. Check the expiration date on the packaging and do not use beyond the stated shelf life.
Packaging Description
Corvalazid is available in a 25 ml vial for oral administration.
Clinical Evidence and Proven Effectiveness
Clinical studies have shown that Corvalazid effectively reduces symptoms of anxiety and promotes relaxation in individuals with anxiety disorders. The combination therapy of ethyl ether of α-bromisovaleric acid and phenobarbital has demonstrated significant improvements compared to placebo in managing anxiety.